Form 4: Precision BioSciences CEO Michael Amoroso Increases Stake in Company Through Private Placement

Michael Amoroso, President and CEO of Precision BioSciences, acquired 8,334 shares of common stock through a private placement at $12 per share.

Summary

• Michael Amoroso, the President and CEO of Precision BioSciences, acquired 8,334 shares of the company's common stock on May 8, 2024.
• The shares were purchased through a non-brokered private placement at a price of $12 per share.
• Following the transaction, Amoroso directly owns 22,106 shares of Precision BioSciences.
• The purchase was made pursuant to a definitive subscription agreement with certain members of management.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the CEO's purchase of shares indicates confidence in the company. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• The CEO's investment in the company may signal confidence in Precision BioSciences' future prospects.
• The private placement provides the company with additional capital.

Industry Context

Insider transactions are closely watched by investors as they can provide insights into management's perspective on the company's value and future performance. A purchase by the CEO is generally viewed positively.

Stakeholder Impact

• Shareholders may view the CEO's purchase as a positive signal.
• The company benefits from the additional capital raised through the private placement.

Key Dates